We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.25 | 1.10 | 1.40 | 1.25 | 1.25 | 1.25 | 592,472 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -3.57 | 1.69M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/7/2020 20:16 | Pyc have been 'talking to over 50 clients' for the past 3 years. They have been flogging this dead horse for 20 years, it's not like anyone isn't gonna know about pyc. None of the pharmas really need pyc, that's the problem, they do dose prediction themselves. If they need real a.i work done they will go to the bigger companies that have a broader range of skills. How many more years are you gonna keep ramping this Stig? | davevt | |
24/7/2020 19:30 | Looks like we are developing a lovely Bull Flag folks which have been reliable continuation patterns I could never have imagined we'd be at c. 10p prior to the next Big Pharma contract When Physiomics anoounced the 'old news' about Merck in November 2017 we went up from 1p to 32p It doesn't bear thinking about how high we could go on next Big Pharma contract Physiomics talking to well over 50 clients... at some point we will see the Domino Effect kick in If you are in this sector developing cancer drugs I don't think you can afford to be without Physiomics VT Look at the success of our clients like Bicycle Therapeutics, Cyclacel, Merck KGaA (which partners with GSK and Pfizer in Immuno-oncology) | the stigologist | |
24/7/2020 18:28 | Every customer is a LARGE pharma, it doesn't make any difference. The frequency of work will always be low, because pyc only do one thing. And no Stig, personalized oncology isn't big for pyc, because all pyc do is dose prediction....that's it. And is moot, because no matter what dose pyc think maybe best for a patient, if the patient suffers side effects they can't handle, it's the patient that ultimately dictates what dose they want. | davevt | |
24/7/2020 16:20 | Usual Friday afternoon sell off for punters weekend six pack. | charlesjames1 | |
24/7/2020 16:10 | All very positive. I can only see upside here. | hodhasharon | |
24/7/2020 16:08 | Regardless of news about our NEW LARGE PHARMA customer we can expect imminent news on - Trading Update for year end June 30th - News re new Employee recruitment - leftfield news or repeat business from our many other Biotech/Pharma clients (PYC talking to 50+ clients) - the real biggie for PYC is Personalised Oncology - crack this and we could become a £1bn+ Unicorn in Cancer AI | the stigologist | |
24/7/2020 16:03 | Good afternoon hitman, did you close that short? | hazelst | |
24/7/2020 16:00 | not here pal. | thehitman1 | |
24/7/2020 15:59 | look up imminent please, you have been saying that for almost a year now. | thehitman1 | |
24/7/2020 15:51 | So some of the wiser investors are preparing for the imminent news. | ant15 | |
24/7/2020 15:48 | 17p close anyone? | hodhasharon | |
24/7/2020 15:35 | Looks like DaTIT has gone off to open up his Indian Restaurant. | hodhasharon | |
24/7/2020 15:24 | Thanks Stig | ambyth | |
24/7/2020 15:18 | Here it goes into double digits | tmmalik | |
24/7/2020 15:11 | Here you go | the stigologist | |
24/7/2020 15:02 | Stig > Can you post the actual link to Myles' tweet about PYC please? (For some reason I can't seem to find it on Twitter.) Thanks. | ambyth | |
24/7/2020 14:44 | Excellent news that Myles is in. He's a good man to follow on Twitter, this time though I am ahead of him instead of being led by him! Awesome! | hickersp | |
24/7/2020 14:39 | Myles McNulty the AVCT guru who ten bagged his investment has now bought Physiomics PYC I believe Myles is an intelligent fellow and if he reads PYC's RNSes about their proprietary Virtual Tumour cancer model, notes the validation of Big Pharma,Leading Biotechs, UK Govt, Britain's leading Cancer Research Institutes (CRUK Cancer Research UK, ICR Institute of Cancer Research), Oxford Uni and the NHS he will realise PYC is his next big winner | the stigologist | |
24/7/2020 14:10 | It's nice to have AVCT guru Myles McNulty investing in PYC But how many AVCT investors would invest in PYC if say Avacta Cancer Therapeutics division signed a deal to use Physiomics' Modelling and Simulation products in the pre-clinical and clinical development of their Affimer and PreCision TMAC cancer therapeutics ! AVCT Mkt Cap £300m+ PYC Mkt Cap £10m Only needs a few AVCT Insitutions and PIs to 'diversify' into PYC for PYC to go nuts | the stigologist | |
24/7/2020 14:07 | DaTIT still knocking about I see. | sapper2476 | |
24/7/2020 13:51 | The rise has gone in a puff 🤣🤣 | datait | |
24/7/2020 13:49 | go away you little puff | hodhasharon | |
24/7/2020 13:47 | 🤣🤣 Timrrrrrrrrrrrr Dilution next news mugs | datait |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions